mrecht@cooley.com
For over 20 years, Marc Recht has represented life sciences and other healthcare companies and investors in public and private transactions, including securities offerings, joint ventures and M&A matters. He also has extensive experience advising public companies boards of directors and management teams regarding Securities and Exchange Commission periodic disclosure, Sarbanes-Oxley compliance, corporate governance and Nasdaq and New York Stock Exchange rules.
Download full bio
Exscientia – $510.4 Million IPO
Exscientia Inks Investment of up to $525 Million
Talaris Therapeutics – $150 Million IPO
Celularity to Go Public Through SPAC Merger
Oncorus – $98 Million IPO
View all
Public Companies
Capital Markets
Life Sciences
Mergers & Acquisitions
Emerging Companies
Medtech
Digital Health
Venture Capital
Road cycling
Skiing
Excellent in all categories. Marc Recht is 'very technically skilled in corporate matters and plays a strong quarterback role.'
Boston College Law SchoolJD, magna cum laude, 1999
Brandeis University BA, with honors, 1995
Massachusetts
Exscientia – $510.4 Million IPO October 5, 2021
Chambers USA 2021 Recognizes Cooley Lawyers + Practices May 28, 2021
Exscientia Inks Investment of up to $525 Million May 10, 2021
Chambers USA: Capital Markets –Massachusetts (2014-2021)
The Legal 500 US: Healthcare: Life Sciences (2013, 2016, 2020)
Who's Who Legal: Life Sciences (2017, 2018)
Super Lawyers: Rising Star (2007, 2010 – 2013)
Boston Business Journal: Biotech IPO (2015)
+1 617 937 2316
Locations